The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention
Decision Aid to Improve Coronary Heart Disease Risk Modification: a Pilot Randomized Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
The purpose of this study is to determine whether providing patients with information about their global coronary heart disease (CHD) risk and effective risk-reducing strategies allows them to make appropriate decisions about heart disease prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2003
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2004
CompletedFirst Submitted
Initial submission to the registry
April 17, 2006
CompletedFirst Posted
Study publicly available on registry
April 19, 2006
CompletedJuly 10, 2007
April 1, 2006
April 17, 2006
July 9, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Discussion with provider about CHD risk reduction
Stated plans for CHD risk reduction
Secondary Outcomes (3)
Knowledge about CHD prevention
Perception of CHD risk
Interest in participating in decision-making
Interventions
Eligibility Criteria
You may qualify if:
- presenting for routine medical care with regular medical provider
- able to understand, speak, and read English
You may not qualify if:
- prior history of cardiovascular disease
- history of serious medical illness that would limit candidacy for screening
- previous participation in intensive risk modification as part of diabetes study in our clinic
- no cholesterol measurement in the last 3 years, limiting ability to provide up-to-date risk estimate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Related Publications (1)
Sheridan SL, Shadle J, Simpson RJ Jr, Pignone MP. The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Serv Res. 2006 Sep 27;6:121. doi: 10.1186/1472-6963-6-121.
PMID: 17005051RESULT
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Stacey L. Sheridan, MD, MPH
University of North Carolina, Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 17, 2006
First Posted
April 19, 2006
Study Start
June 1, 2003
Study Completion
February 1, 2004
Last Updated
July 10, 2007
Record last verified: 2006-04